The bankruptcy of genetic-testing pioneer 23andMe is a powerful cautionary tale. After going public in 2021 with a $3.5 billion valuation, the company’s market cap plummeted to less than $13.5 million ...
Humans love to play with their food—in fact, we’ve been doing it for thousands of years. In this episode of Crash Course Botany, we explore how we’ve learned to manipulate plant genetics, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback